60 Degrees Pharmaceuticals: updates presentation and Jan 2027 readout

What happened On Oct 6, 2026 the company updated its investor presentation, which it intends to use from time to time in meetings with investors, analysts and other members of the investment community. A copy of the updated investor presentation is furnished as Exhibit 99.1 to the Current Report on Form 8-K. On Oct 6, 2026 the company also issued a press release announcing an update to its Jan 2027 hospitalized babesiosis data readout; the press release is attached as Exhibit 99.2 to the Current Report on Form 8-K.

Key details

• Date: Oct 6, 2026.
• Item reported: updated investor presentation (furnished as Exhibit 99.1).
• Item reported: press release announcing an update to the Jan 2027 hospitalized babesiosis data readout (attached as Exhibit 99.2).

Why it may matter The filing reports Item 7.01 (Regulation FD disclosure) and Item 8.01 (other events); Item 7.01 covers the updated investor presentation and Item 8.01 covers the press release about the Jan 2027 hospitalized babesiosis data readout. A filing does not show why the insider traded or why the company acted.